Marimed Financials
| MRMD Stock | USD 0.14 0.01 6.67% |
With this module, you can analyze Marimed financials for your investing period. You should be able to track the changes in Marimed individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Marimed |
The data published in Marimed's official financial statements typically reflect Marimed's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Marimed's quantitative information. For example, before you start analyzing numbers published by Marimed accountants, it's essential to understand Marimed's liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Please note, the presentation of Marimed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Marimed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Marimed's management manipulating its earnings.
Marimed Stock Summary
Marimed competes with Verano Holdings, Cresco Labs, AYR Strategies, Green Thumb, and Trulieve Cannabis. MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts. Marimed operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 260 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| ISIN | US56782V1070 |
| Business Address | 10 Oceana Way, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.marimedinc.com |
| Phone | 617 795 5140 |
| Currency | USD - US Dollar |
Marimed Key Financial Ratios
There are many critical financial ratios that Marimed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Marimed reports annually and quarterly.| Return On Equity | 0.0303 | |||
| Return On Asset | 0.0921 | |||
| Target Price | 0.98 | |||
| Number Of Employees | 260 | |||
| Beta | 3.06 |
Marimed Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Marimed's current stock value. Our valuation model uses many indicators to compare Marimed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Marimed competition to find correlations between indicators driving Marimed's intrinsic value. More Info.Marimed is regarded fifth in return on equity category among its peers. It is regarded second in return on asset category among its peers reporting about 3.04 of Return On Asset per Return On Equity. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Marimed's earnings, one of the primary drivers of an investment's value.Marimed Systematic Risk
Marimed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Marimed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Marimed correlated with the market. If Beta is less than 0 Marimed generally moves in the opposite direction as compared to the market. If Marimed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Marimed is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Marimed is generally in the same direction as the market. If Beta > 1 Marimed moves generally in the same direction as, but more than the movement of the benchmark.
Marimed December 3, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Marimed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Marimed. We use our internally-developed statistical techniques to arrive at the intrinsic value of Marimed based on widely used predictive technical indicators. In general, we focus on analyzing Marimed OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Marimed's daily price indicators and compare them against related drivers.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 28.1 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 6.67 |
Complementary Tools for Marimed OTC Stock analysis
When running Marimed's price analysis, check to measure Marimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marimed is operating at the current time. Most of Marimed's value examination focuses on studying past and present price action to predict the probability of Marimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marimed's price. Additionally, you may evaluate how the addition of Marimed to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |